(MedPage Today) — A promising new way to diagnose transthyretin amyloid cardiomyopathy (ATTR-CM or -CA) has the field waiting in anticipation.
Early-phase research suggests that the positron emission tomography (PET)/CT pan-amyloid tracer iodine…

Read the full article on medpagetoday.com